Compare Ganges Securitie with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 1.01%
- Poor long term growth as Net Sales has grown by an annual rate of -0.33% and Operating profit at -25.70%
Negative results in Dec 25
With ROE of 0.2, it has a Very Expensive valuation with a 0.2 Price to Book Value
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
Ganges Securitie for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ganges Securities Ltd is Rated Strong Sell
Ganges Securities Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 25 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Ganges Securities Ltd is Rated Strong Sell
Ganges Securities Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 25 August 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 07 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Markets Rally, But Ganges Securities Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off
Despite a broadly positive market environment, Ganges Securities Ltd has plunged to a fresh 52-week low of Rs 98.2 on 1 Apr 2026, marking a 5.12% decline on the day and extending a three-day losing streak that has erased over 11% of its value. This stark underperformance contrasts sharply with the Sensex’s 2.66% gain and highlights persistent headwinds facing the micro-cap FMCG player.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Apr-2026 | Source : BSECopy of Newspaper Publication
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Apr-2026 | Source : BSECertificate in terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
Closure of Trading Window
27-Mar-2026 | Source : BSEClosure of Trading window
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 1 FIIs (0.03%)
Sil Investments Limited (13.38%)
Navjeewan Medical Institute (6.21%)
21.69%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -14.20% vs 1.00% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 82.50% vs -40.30% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -4.41% vs 19.10% in Sep 2024
Growth in half year ended Sep 2025 is -52.87% vs 35.93% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -7.98% vs 11.81% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -41.05% vs 22.30% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 9.08% vs -15.57% in Mar 2024
YoY Growth in year ended Mar 2025 is 45.40% vs -64.31% in Mar 2024






